FDA Chief Counsel, Daniel Troy, Resigned Wed, 17 Nov 2004 FDA’s chief counsel, Daniel Troy, has resigned! This is good news for consumers. Troy was the symbol of what is rotten at the FDA: the pharmaceutical industry’s influence has ensured that business interests take precedence over public safety. Industry-influenced advisory…
Texas Foster Care Investigation – Children as young as 3 are drugged with antipsychotics Sat, 13 Nov 2004 The Dallas Morning News reports that Texas comptroller, Carole Keeton Strayhorn, who hade conducted an investigation of the foster care system, concluded that up to $4 million a year might be wasted…
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086 New York, NY 10023 www.ahrp.org November 1, 2004 Thomas W. Abrams Director Office…
FDA Protects Pfizer: Removes Advisory Panelist for Citing Evidence Bextra Similar to Vioxx – WSJ Fri, 12 Nov 2004 Even as the Vioxx casualties are still being counted, even as FDA’s conduct is under Congressional investigation, the FDA office of new drugs has taken action to obstruct evidence-based safety evaluation…
FDA Condones False Advertising about anthrax vaccine Thu, 9 Dec 2004 The FDA and the Pentagon are flagrantly violating the law and a U.S. Court ruling. On October 27, 2004, a US Court ordered the Pentagon to suspend its forced anthrax vaccination of military personnel, and the Court ordered the…
2/3 Institute of Medicine AIDS research panel have Conflicts of Interst – Assoc Press Thu, 17 Mar 2005 On Feb 25, the New York Times reported that 10 of 32 FDA panelists determining whether to recommend that COX 2 painkillers should allowed to be marketed despite the documented increased risk…
Pfizer Zoloft Warnings to Canadian Doctors Contrast to US – FDA Caves In to Pharma lobbying Thu, 10 Feb 2005 The FDA has, once again, quietly colluded with industry, compromising the safety of children’s lives to maintain drug manufacturers’ cash flow. After two FDA advisory committee hearings (Feb 2-3 and…
Senator Says FDA Asked Canada NOT to Suspend Adderall, Drug used for ADHD – NYT Fri, 11 Feb 2005 The New York Times reports that not only has the FDA failed to act to protect children and adults from a drug that has been linked to about 20 sudden deaths,…
Efforts to promote Cymbalta for Fibromyalgia symptoms Wed, 20 Oct 2004 Cymbalta (duloxetine) was approved by the FDA as a treatment for depression in adults. No doubt in an effort to expand the drugs’ market, Eli Lilly tested the drug in patients with fibromyalgia. The published report claims women who…
SEC Focusing on Drug Makers Disclosure_ Continuing Medical Ed Changes Tue, 28 Sep 2004 Evidence showing that drug manufacturers and the FDA concealed negative clinical trial data and deceived physicians, consumers, and shareholders about failure to demonstrate the safety and effectiveness of SSRI antidepressant drugs has caught the interest of…
Govt Prozac study Recommends MANDATORY Screening & Drugs – “Overdosed America”_OpEd NYT Sun, 19 Sep 2004 FDA’s Review of Safety & Efficacy Concerns in Anti-Depressant Use by Children is the subject of a second Congressional hearing by the House Energy & Commerce Subcommittee on Oversight / Investigations on September 23,…
18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different Tue, 21 Sep 2004 The FDA failed to stop drug manufacturers from flooding the air waves and the scientific literature with false and scientifically invalid claims-based on partial data. “The FDA…
